לבטיראצטם טבע ® 1000 מ"ג

Land: Israel

Sprache: Hebräisch

Quelle: Ministry of Health

Wirkstoff:

LEVETIRACETAM 1000 MG

Verfügbar ab:

TEVA PHARMACEUTICAL INDUST.LTD

ATC-Code:

N03AX14

Darreichungsform:

TABLETS

Verabreichungsweg:

PER OS

Hergestellt von:

TEVA PHARMACEUTICAL INDUSTRIES LTD

Therapiegruppe:

LEVETIRACETAM

Anwendungsgebiete:

- Levetiracetam is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - Levetiracetam is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.- Levetiracetam is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patient from 16 years of age with newly diagnosed epilepsy.- Levetiracetam is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

Berechtigungsdatum:

2009-09-01